Antimicrobial Resistance in Staphylococcus

Staphylococcus aureus is a bacterial pathogen capable of causing infections ranging from minor skin conditions to life-threatening bloodstream and organ infections, and its methicillin-resistant form, MRSA, has become one of the most closely watched threats in modern medicine because it evades the antibiotics most commonly used to treat it. Researchers study how resistance genes spread between strains and between healthcare settings and communities, how specific virulence factors enable the bacterium to damage tissue and defeat immune defenses, and how clinicians can optimize the remaining effective drugs—particularly vancomycin—as resistance to those agents also begins to emerge. A central open question is why certain MRSA lineages succeed in particular environments, whether in hospitals or among otherwise healthy people outside them, and what genetic or evolutionary pressures drive that divergence. Translating genomic surveillance data into faster, more targeted clinical decision-making remains an active and pressing challenge.

Works

125,183

Total citations

2,078,882

Keywords

MRSAStaphylococcus aureusAntimicrobial ResistanceEpidemiologyClinical ManagementVirulence Factors